Education
About Us
Working with TipRanks
Follow Us
Exozymes Inc. (EXOZ)
:EXOZ
EXOZ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.50 - $23.99
Previous CloseN/A
VolumeN/A
Average Volume (3M)9.45K
Market Cap
N/A
Enterprise Value$129.74M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)1.38M
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Apr 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,367,810
10 Day Avg. Volume4,438
30 Day Avg. Volume9,449
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1321.52
Price to Cash Flow (P/CF)-42.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
eXoZymes News
PremiumCompany Announcements
eXoZymes Inc. Reports 2024 Progress and IPO Success
PremiumCompany Announcements
eXoZymes Announces Leadership Changes with New Appointments
---
Options Prices
Currently, No data available
---
Ownership Overview
56.30% Insiders
0.62% Mutual Funds
― Other Institutional Investors
42.46% Public Companies and
Individual Investors
EXOZ FAQ
What was Exozymes Inc.’s price range in the past 12 months?
Exozymes Inc. lowest stock price was $8.50 and its highest was $23.99 in the past 12 months.
What is Exozymes Inc.’s market cap?
Currently, no data Available
When is Exozymes Inc.’s upcoming earnings report date?
Exozymes Inc.’s upcoming earnings report date is Apr 02, 2025 which is 16 days ago.
How were Exozymes Inc.’s earnings last quarter?
Exozymes Inc. released its earnings results on Apr 02, 2025. The company reported -$0.219 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.219.
Is Exozymes Inc. overvalued?
According to Wall Street analysts Exozymes Inc.’s price is currently Overvalued.
Does Exozymes Inc. pay dividends?
Exozymes Inc. does not currently pay dividends.
What is Exozymes Inc.’s EPS estimate?
Exozymes Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exozymes Inc. have?
Exozymes Inc. has 8,367,810 shares outstanding.
What happened to Exozymes Inc.’s price movement after its last earnings report?
Exozymes Inc. reported an EPS of -$0.219 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.162%.
Which hedge fund is a major shareholder of Exozymes Inc.?
Currently, no hedge funds are holding shares in EXOZ
---
Company Description
Exozymes Inc.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
---
EXOZ Earnings Call
Q4 2025
0:00 / 0:00
---
Technical Analysis
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Denali Therapeutics
―
Twist Bioscience
―
---